Contingency Management for Alcohol Use Disorders

Status

Completed

Phases

Study type

Interventional

Source

ClinicalTrials.gov

Registry ID

NCT02135237

Enrollment

120

Registered

2014-05-09

Start date

2014-01-31

Completion date

2019-06-30

Last updated

2019-11-01

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Alcohol Use Disorder, Contingency Management

Brief summary

Contingency management (CM) treatments are highly efficacious in improving outcomes of substance abusing patients. However, CM has rarely been applied to individuals with alcohol use disorders, primarily because of technological limitations in monitoring drinking. The Secure Continuous Remote Alcohol Monitor (SCRAMx®) is a new technology designed to continuously monitor alcohol consumption 24 hours a day for 7 days per week. The purpose of this study is to evaluate the efficacy of CM in reducing alcohol use using SCRAMx. In total, 120 alcohol abusing or dependent patients initiating outpatient treatment at community-based clinics will be randomly assigned to one of two conditions: standard care, or standard care plus CM with reinforcement based on results of SCRAMx readings. Compared with standard care, it is expected that CM will result in fewer drinking days and longer durations of continuous non-drinking days.

Interventions

BEHAVIORALPrize Contingency Management for Alcohol Abstinence

The systematic reinforcement of desired behaviors and the withholding of reinforcement for undesired behaviors

BEHAVIORALStandard Care

Study design

Allocation

RANDOMIZED

Intervention model

PARALLEL

Primary purpose

TREATMENT

Masking

NONE

Eligibility

Sex/Gender

ALL

Age

18 Years to No maximum

Healthy volunteers

Inclusion criteria

* age 18 years or older * current diagnosis of alcohol use disorder and self report of recent alcohol use * pass an informed consent quiz * agree to wear a SCRAMx monitor for 12 weeks * have a standard SCRAMx compatible phone line in their home or agree to attend the clinic weekly for brief research visits/downloads * agree to sign an off-campus property transfer form and return SCRAMx equipment

Exclusion criteria

* serious, uncontrolled psychiatric illness * in recovery from pathological gambling * have an unstable address * intend to participate in activities incompatible with SCRAMx over the next 3 months * are wearing SCRAMx for legal purposes

Design outcomes

Primary

Measure	Time frame	Description
longest duration of abstinence from alcohol	three months	objective report of alcohol use as measured by SCRAMx device

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026